Skip to main content
See every side of every news story
Published loading...Updated

Taysha Gene Therapies, Canaan, Ondas Holdings And Other Big Stocks Moving Higher On Thursday - Angel Studios (NYSE:ANGX)

Summary by Benzinga
U.S. stocks were mixed, with the Dow Jones index falling more than 50 points on Thursday. Shares of Taysha Gene Therapies Inc (NASDAQ:TSHA) rose sharply during Thursday's session after the FDA granted the company Breakthrough Therapy designation to TSHA-102 for the treatment of Rett syndrome. Needham analyst Gil Blum maintained Taysha Gene Therapies with a Buy and raised the price target from $8 to $10. Taysha Gene Therapies shares jumped 50.4% …

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

rettsyndrome.org broke the news in on Thursday, October 2, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal